Link to the original source is as follows(might not be available now):
https://drive.infomaniak.com/app/share/475026/4aef7d10-2b2a-49cf-96ef-9dc58795dc59/files/1794
I'm archiving Metabiota emails from Hunter Biden's laptop. There were more than 250 pdf files, but many of them were redundant(multiple files with the same content). I'll try to archive them in chronological order here. Hopefully, those emails could provide a glimpse of what was going on with Hunter Biden and Metabiota.
Metabiota is a pathogen research company associated with Hunter Biden's investment company Rosemont Seneca Partners and also Ukrainian bio-labs. Check my previous posts for more information:
Hunter Biden was involved in Ukrainian bio-labs
Wikipedia deleted entry of Rosemont Seneca Partners, Hunter Biden's company.
Also, Metabiota is one of "2021 Technology Pioneers" selected by the World Economic Forum.
The following emails are from Sep. 17, 2014. I redacted usernames and phone numbers from the original version.
Fwd_ RSTP Growth Equity Update(3).pdf
From: John DeLoche <(redacted)@rosemontseneca.com>
Sent: Wednesday, September 17, 2014 at 06:09:00 PM CEST
To: "(redacted)
Cc: (redacted)@rosemontseneca.com, "(redacted)
Bcc:
Reply-To:
Priority: Low
Subject: Fwd: RSTP Growth Equity Update
Hunter,
These are the guys you and I met with in Baltimore in 2012. They have told me they have an allocation for us. This is the closing meeting with Scott and his investment committee. It is in Baltimore next Thursday at 9:30am. Would be great if you can make it.
Best,
John
Sent from my iPhone
Begin forwarded message:
From: "Soffen, Scott" <(redacted)@ATAPCO.COM>
Date: September 17, 2014 at 8:14:38 AM PDT
To: John DeLoche <(redacted)
Cc: William Lee <(redacted)
Subject: RE: RSTP Growth Equity UpdateWe are confirmed for Sept 25 at 9:30AM.
Scott Soffen, CFA, CAIA
American Trading and Production Corporation
One South Street
Suite 2800
Baltimore, MD 21202
(410) (redacted)From: John DeLoche [mailto:(redacted)
Sent: Tuesday, September 16, 2014 7:43 PM
To: Soffen, Scott
Cc: William Lee; Neil Callahan; Devon Archer
Subject: Re: RSTP Growth Equity UpdateHi Scott,
Sorry for the delay as we have been on the road. 9:30 at your offices next Thursday, 25th works well for us. We look forward to it.
Best,
JohnJohn DeLoche
Co-founder and Managing Director
Rosemont Seneca Technology Partners
333 Bush Street, 21st Floor
San Francisco, CA 94104
office: 415 (redacted)
mobile: 415 (redacted)This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail.
On Mon, Sep 8, 2014 at 10:52 AM, Soffen, Scott <(redacted)
> wrote:
Sounds good. Does 9:30am work for you?
Scott Soffen, CFA, CAIA
Typos courtesy of Siri!On Sep 8, 2014, at 1:31 PM, "John DeLoche" <(redacted)
Hi Scott,
How about Thursday, September 25th in the morning at your offices in Baltimore?Best,
JohnJohn DeLoche
Co-founder and Managing Director
Rosemont Seneca Technology Partners
333 Bush Street, 21st Floor
San Francisco, CA 94104
office: 415 (redacted)
mobile: 415 (redacted)This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail.
On Thu, Sep 4, 2014 at 7:34 AM, Soffen, Scott <(redacted)
Hi John:
I’d love to get an update. I have time as follows:
- Generally available in Baltimore all month
- In Washington DC on Sept 8 and 9
- In San Francisco, with time available on the afternoon of Oct 7
Just let me know what works best for you.
Scott Soffen, CFA, CAIA
American Trading and Production Corporation
One South Street
Suite 2800
Baltimore, MD 21202
(410) (redacted)From: John DeLoche [mailto:(redacted)
Sent: Wednesday, September 03, 2014 8:08 PM
To: Soffen, Scott
Cc: Hunter Biden; William Lee; Neil Callahan; Devon Archer
Subject: RSTP Growth Equity UpdateHi Scott,
I hope you had a great summer. I was able to get out to the Jersey shore a few times and it was great out there. I wanted to follow up as discussed and send you our updated fund docs (attached).
We also wanted to update you on Rosemont Seneca Technology Partners key milestones and get on your calendar for an update meeting before the final closing of RSTP II. Recent RSTP milestones:
- Closed and circled over $150 million from institutional investors including Neuberger Berman, Goldman Sachs andothers
- RSTP became the largest and sole institutional investor in Metabiota, a profitable software and services company that is digitizing the world's microbial threats. The recent Ebola crisis has highlighted the importance of Metabiota's work with governments, livestock producers and insurance companies globally. We expect a co-investment opportunity in Metabiota for RSTP LPs in Q4. A recent Op-Ed in Time.com by Metabiota's CEO is included here: http://time.com/3069876/ebola-outbreak-truth/
- RSTP portfolio company Counsyl, in which several of our LPs Co-invested directly, is growing explosively and preparing for an IPO. Some recent press on Counsyl is included here: http://www.sfgate.com/technology/article/Counsyl-gets-funding-for-new-genetic-tests-5462605.php
We will be in NY often this month and could also swing down for a Baltimore meeting. Alternatively, we would be happy to host you in our NY, DC or SF offices. Please let us know what works.
Best,
JohnJohn DeLoche
Co-founder and Managing Director
Rosemont Seneca Technology Partners
333 Bush Street, 21st FloorSan Francisco, CA 94104
office: 415 (redacted)
mobile: 415 (redacted)
This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail.